Challenges in validating quality of care data in a schizophrenia registry: Experience from the Danish national Indicator Project

Clinical Epidemiology

Volumn 4, Issue 1, 2012, Pages 201-207

  Pedersen, Charlotte Gjørup ^a   Gradus, Jaimie L ^b   Johnsen, Søren Paaske ^c   Mainz, Jan ^a,d  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b BOSTON UNIVERSITY   (United States)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Quality of care; Registry; Schizophrenia; The Danish National Indicator Project; Validation

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; CONTROLLED STUDY; DANISH; DENMARK; DISEASE REGISTRY; ETHNIC GROUP; FEMALE; GOLD STANDARD; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; INFORMATION RETRIEVAL; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MEDICAL RECORD; MENTAL DISEASE; POPULATION RESEARCH; PREDICTIVE VALUE; PRESCRIPTION; PSYCHOEDUCATION; PSYCHOSOCIAL CARE; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SENSITIVITY AND SPECIFICITY; SUICIDE; VALIDATION PROCESS;

EID: 84866033808     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/clep.s29419     Document Type: Review

References (26)

1. Sørensen HT, Sabroe S, Olsen J. A framework for evaluation of secondary data sources for epidemiological research. Int J Epidemiol. 1996; 25(2):435-442.
2. Olsen J. Using secondary data. In: Rothman KJ, Greenland S, Lash TL, editors. Modern Epidemiology, 3rd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2008:481-491.
3. Byrne N, Regan C, Howard L. Administrative registers in psychiatric research: a systematic review of validity studies. Acta Psychiatr Scand. 2005;112(6):409-414.
4. Hermann RC. Improving Mental Healthcare: A Guide to Measurement-Based Quality Improvement. Washington DC: American Psychiatric Press, Inc; 2005.
5. Pedersen CB. The Danish Civil Registration. Scand J Public Health; 2011; 39 (7 Suppl): 22-25.
6. Mainz J, Krog BR, Bjørnshave B, et al. Nationwide continuous quality improvement using clinical indicators: the Danish National Indicator Project. Int J Qual Health Care. 2004;16:i45-i50.
7. Danish National Board of Health. The Danish National Indicator Project Audit Schizophrenia [webpage on the Internet]. Aarhus: Danish National Board of Health; 2009. Available from: http://www.nip.dk/. Accessed December 15, 2011. Danish.
8. World Health Organization. International Statistical Classification of Diseases and Related Health Problems (ICD). 10th Revision. Geneva: World Health Organization; 2012. Available from: http://www.who.int/classifications/icd/en/. Accessed March 28, 2012.
9. Tsai J, Bond G. A comparison of electronic records to paper records in mental health centers. Int J Qual Health Care. 2008;20(2):136-143.
10. Sequist TD, Gandhi TK, Karson AS, et al. A randomized trial of electronic clinical reminders to improve quality of care for diabetes and coronary artery disease. J Am Med Inform Assoc. 2005;12(4):431-437.
11. Shojania KG, Jennings A, Mayhew A, Ramsay C, Eccles M, Grimshaw J. Effect of point-of-care computer reminders on physician behaviour: a systematic review. CMAJ. 2010;182(5):E216-E225.
12. Wolff AM, Taylor SA, McCabe JF. Using checklists and reminders in clinical pathways to improve hospital inpatient care. Med J Aust. 2004; 181(8):428-431.
13. Boonstra A, Broekhuis M. Barriers to the acceptance of electronic medical records by physicians from systematic review to taxonomy and interventions. BMC Health Serv Res. 2010;10:231.
14. Davis JM, Chen N, Glick ID. A meta-analysis of the efficacy of second-generation antipsychotics. Arch Gen Psychiatry. 2003;60(6): 553-564.
15. Geddes J, Freemantle N, Harrison P, Bebbington P. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ. 2000;321(7273):1371-1376.
16. Leucht S, Wahlbeck K, Hamann J, Kissling W. New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis. Lancet. 2003;361(9369):1581-1589.
17. Tuunainen A, Wahlbeck K, Gilbody SM. Newer atypical antipsychotic medication versus clozapine for schizophrenia. Cochrane Database Syst Rev. 2000;CD000966.
18. Pharoah FM, Mari JJ, Streiner D. Family intervention for schizophrenia. Cochrane Database Syst Rev. 2000;CD000088.
19. Pilling S, Bebbington P, Kuipers E, et al. Psychological treatments in schizophrenia: II. Meta-analyses of randomized controlled trials of social skills training and cognitive remediation. Psychol Med. 2002; 32(5):783-791.
20. Pitschel-Walz G, Leucht S, Bauml J, Kissling W, Engel RR. The effect of family interventions on relapse and rehospitalization in schizophrenia-a meta-analysis. Schizophr Bull. 2001;27(1):73-92.
21. Pekkala E, Merinder L. Psychoeducation for schizophrenia. Cochrane Database Syst Rev. 2002;CD002831.
22. Merinder LB. Patient education in schizophrenia: a review. Acta Psychiatr Scand. 2000;102(2):98-106.
23. Zygmunt A, Olfson M, Boyer CA, Mechanic D. Interventions to improve medication adherence in schizophrenia. Am J Psychiatry. 2002;159(10):1653-1664.
24. Marshall M, Lockwood A. Assertive community treatment for people with severe mental disorders. Cochrane Database Syst Rev. 2000; CD001089.
25. Wing JK, Babor T, Brugha T, et al. SCAN. Schedules for clinical assessment in neuropsychiatry. Arch Gen Psychiatry. 1990;47(6):589-593.
26. Wing JK, Birley JL, Cooper JE, Graham P, Isaacs AD. Reliability of a procedure for measuring and classifying "present psychiatric state. " Br J Psychiatry. 1967;113(498):499-515.